(all times are US Eastern)
Friday November 6, 2009

• Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting
  9:00 am - PR Newswire
• GeoVax Labs, Inc. Provides Third Quarter 2009 Financial Results and Operational Update
  9:00 am - PR Newswire
• RiskMetrics Group Recommends Stockholders Vote "FOR" Life Sciences Research/Lion Holdings Merger
  9:00 am - Business Wire
• LabCorp is Scheduled to Present at the Credit Suisse 18th Annual Healthcare Conference
  9:00 am - Business Wire
• Calbiotech Awarded U.S. Army Phase I SBIR Research Contract to Develop Analyte Specific Reagents for the Diagnosis of Dengue Fever Virus
  8:35 am - PR Newswire
• Immunomedics Announces First Quarter Fiscal 2010 Results and Clinical Program Developments
  8:30 am - GlobeNewswire
• Boston Scientific Announces Agreement With DOJ On Pre-Acquisition Investigation of Guidant
  8:30 am - PR Newswire
• Global Biotech Corp. Announces Listing on CNSX
  8:30 am - Marketwire
• Genetix Pharmaceuticals Announces Global Clinical Plans to Treat Adrenoleukodystrophy (ALD)
  8:30 am - Business Wire
• QuantRx Debuts Flagship Diagnostic Reader Device (Q-Reader) at MEDICA 2009, the World's Leading Medical Trade Fair
  8:22 am - Business Wire
• UPDATE - Par Pharma Q3 profit beats estimates on strong revenue
  8:20 am - at Reuters
• Sucampo Pharmaceuticals Invites Investors to Listen to Webcast of Presentation at Credit Suisse Conference
  8:15 am - Business Wire
• SPECIAL REPORT-Are doctors what ails U.S. healthcare?
  8:04 am - at Reuters
• UPDATE - GLG Life Tech to offer 3.6 mln shares for US IPO
  8:00 am - at Reuters
• Rand Capital Announces $250,000 Investment in Rheonix, Inc.
  8:00 am - GlobeNewswire
• Ardea Biosciences Reports Recent Accomplishments and Announces Third Quarter and Year-to-Date 2009 Financial Results
  8:00 am - PR Newswire
• XOMA Expands Development Strategy for XOMA 052 to Include Cardiovascular Diseases
  8:00 am - GlobeNewswire
• GTC Biotherapeutics Reports Third Quarter 2009 Financial Results
  8:00 am - Business Wire
• NeurogesX Reports Third Quarter 2009 Results
  7:30 am - PR Newswire
• TARIS Appoints Julie Lekstrom Himes, MD, to CMO Post
  7:30 am - Business Wire
• Cytokinetics Announces Addition to Board of Directors
  7:30 am - Marketwire
• Halozyme Therapeutics Reports Third Quarter 2009 Financial Results
  7:29 am - Business Wire
• RXi Pharmaceuticals Appoints Noah D. Beerman as CEO
  7:15 am - Business Wire
• ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology Society
  7:13 am - Business Wire
• EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus
  7:09 am - PR Newswire
• The Quigley Corporation to Announce Third Quarter Results and Host Audio Web Cast
  7:00 am - PR Newswire
• Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2009
  7:00 am - PR Newswire
• Achillion Reports Third Quarter Results
  7:00 am - GlobeNewswire
• Covidien Successfully Completes Tender Offer for Shares of Aspect Medical Systems, Inc.
  7:00 am - Business Wire
• Inhibitex Reports Third Quarter 2009 Financial Results
  7:00 am - Business Wire
• Spectrum Pharmaceuticals Announces Date for Third Quarter 2009 Corporate Update and Pipeline Review Conference Call
  7:00 am - Business Wire
• Evotec to Report Third Quarter 2009 Results on 12 November 2009
  6:33 am - GlobeNewswire
• LAB Research to hold third quarter 2009 financial results conference call and webcast
  6:30 am - CNW Group
• GLG Life Tech Corporation Announces Equity Financing and NASDAQ Listing Application
  6:10 am - Marketwire
• UPDATE - Glaxo gets WHO approval for Synflorix vaccine
  5:45 am - at Reuters
• Amarin Appoints John F. Thero as Chief Financial Officer
  4:15 am - Business Wire
• Agennix AG Shares Begin Trading on Frankfurt Stock Exchange
  3:43 am - Marketwire
• Artimplant Interim Report January - September 2009
  2:56 am - Business Wire
• Smith & Nephew Plc announces 3rd Quarter Results
  1:59 am - Marketwire
• EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and Marketing
  12:01 am - Business Wire

Thursday November 5, 2009

• Quintiles Opens Expanded Asia-Pacific Headquarters in Singapore
  9:30 pm - Business Wire
• Althea Technologies Adds Formulation Development to Its Integrated Offering of Contract Services
  9:20 pm - PR Newswire
• SPECIAL REPORT-Are doctors what ails U.S. healthcare?
  8:04 pm - at Reuters
• Osteotech Reports Third Quarter 2009 Financial Results
  7:30 pm - PR Newswire
• Company sequences whole human genome for $1,700
  7:16 pm - at Reuters
• Ropes & Gray law firm gets insider case black eye
  7:12 pm - at Reuters
• UPDATE - Flu shots for Wall Street stirs ire in New York
  6:43 pm - at Reuters
• Nikkei set to rise after upbeat U.S. jobs news
  6:21 pm - at Reuters
• FDA Approves Labeling Update for REYATAZ® (atazanavir sulfate) Capsules to Include 96-Week Data for Previously Untreated HIV-1 Infected Adult Patients
  6:09 pm - Business Wire
• UPDATE - ResMed quarterly profit jumps 50 percent
  6:05 pm - at Reuters
• Colorado Companies Team Up With U.S. Fish & Wildlife Service to Protect Black-Footed Ferret
  6:05 pm - PR Newswire
• Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
  5:37 pm - PR Newswire
• Boulder Innovation Center Bioscience Program Gets Boost From CU
  5:37 pm - Business Wire
• UPDATE - Genoptix Q3 profit beats Street; raises 2009 EPS view
  5:18 pm - at Reuters
• UPDATE - Tigenix says may raise capital to fund growth
  5:18 pm - at Reuters
• Accellent Inc. Announces Timing of Third Quarter 2009 Earnings Release and Conference Call
  5:18 pm - Business Wire
• FDA Approves Gloucester Pharmaceuticals' ISTODAX® for Patients with Cutaneous T-cell Lymphoma
  4:43 pm - Business Wire
• UPDATE - IMS agrees to $4 bln deal, biggest LBO this year
  4:40 pm - at Reuters
• Purdue Research Foundation to Recognize 32 Faculty and Staff Entrepreneurs, Inventors
  4:40 pm - Business Wire
• iMedicor's CEO and President to Speak with Shareholders
  4:30 pm - Business Wire